During the past decade, Hyogo Cancer Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hyogo Cancer Center" #1 sponsor was "Gynecologic Oncology Group" with 1 trials, followed by "NSABP Foundation Inc" with 1 trials sponsored, "National Cancer Institute (NCI)" with 1 trials sponsored, "Novartis Pharmaceuticals" with 1 trials sponsored and "Yokohama City University" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hyogo Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 2 trials as a collaborator, "NRG Oncology" with 1 trials as a collaborator and "Radiation Therapy Oncology Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Hyogo Cancer Center" are "Atypical Endometrial Hyperplasia" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Head and Neck Cancer" (1 trials), "Human Papillomavirus Infection" (1 trials) and "Ovarian Clear Cell Cystadenocarcinoma" (1 trials). Many other conditions were trialed in "Hyogo Cancer Center" in a lesser frequency.

Most popular intervention types in "Hyogo Cancer Center" are "Drug" (3 trials), "Other" (2 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (2 trials), "Carboplatin" (1 trials), "Cytology Specimen Collection Procedure" (1 trials), "Docetaxel" (1 trials) and "INC280 (capmatinib)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hyogo Cancer Center" are 3 trials for "Female" genders and 2 trials for "All" genders.

Currently, there are NaN active trials in "Hyogo Cancer Center". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Hyogo Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hyogo Cancer Center, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".